-
Mashup Score: 0ANA2020 Media Coverage | American Neurological Association (ANA) - 4 year(s) ago
As always, this year’s ANA Annual Meeting featured a wide array of groundbreaking research. We’re thrilled to share the media coverage that has come out of ANA2020 to date. Please note, many of these publications are behind paywalls, so you’ll need a subscription in order to access the articles.
Source: myana.orgCategories: Latest Headlines, NeurologyTweet
-
Mashup Score: 0
Interview with Argye Elizabeth Hillis MD, MA
Source: PracticeUpdateCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Selective Neuronal Vulnerability in Neurodegenerative Disease - 4 year(s) ago
Interview with Argye Elizabeth Hillis MD, MA
Source: PracticeUpdateCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
Read it now on PracticeUpdate.com
Source: PracticeUpdateCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1Emerging Scholar Award Winners | ANA 2020 - 4 year(s) ago
Congratulations to ANA2020’s first ever Emerging Scholar Award Winners Sixteen presenters showcased their research during one of four ANA2020 Emerging Scholar Lecture Series sessions. All presentations were judged by ANA Fellows based on a set of criterion established by the Scientific Program Advisory Committee. These four represent the top scoring presentation in each of the four sessions.
Source: 2020.myana.orgCategories: Latest Headlines, NeurologyTweet
-
Mashup Score: 0
Interview with Argye Elizabeth Hillis MD, MA
Source: PracticeUpdateCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1CML Drug Nilotinib Shows Early Effects in Alzheimer's Disease - 4 year(s) ago
Preliminary findings for the oral nonantibody drug show safety, significant changes in key Alzheimer’s biomarkers.
Source: MedscapeCategories: Latest Headlines, PsychiatryTweet
-
Mashup Score: 4Poster Awards | ANA 2020 - 4 year(s) ago
Poster Awards were established in 2016 by the Board of Directors as a way to help recognize exceptional work presented by those in the early stages of their careeers – students (graduate and under graduate), residents, trainees and post docs. Posters are judged by members of the Board of Directors, SPAC, Chairs of the SIG Sessions and other leaders in various fields of neurology. The top scoring…
Source: 2020.myana.orgCategories: Latest Headlines, NeurologyTweet
-
Mashup Score: 0CML Drug Nilotinib Shows Early Effects in Alzheimer's Disease - 4 year(s) ago
Preliminary findings for the oral nonantibody drug show safety, significant changes in key Alzheimer’s biomarkers.
Source: MedscapeCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0CML Drug Nilotinib Shows Early Effects in Alzheimer's Disease - 4 year(s) ago
Preliminary findings for the oral nonantibody drug show safety, significant changes in key Alzheimer’s biomarkers.
Source: MedscapeCategories: Latest Headlines, NeurologyTweet
The ANA is thrilled to share the media coverage that came out of #ANA2020! We thank all the researchers who took the time to share their groundbreaking findings with the media. Check it out here: https://t.co/3JiMiAeeYe https://t.co/0erGG1m2v5